ATE8400T1 - 1-carba-6-(1-hydroxyethyl)-2-carbonyl-penem-3carbons[ure, verfahren zur herstellung und sie enthaltende pharmazeutische zusammensetzungen. - Google Patents

1-carba-6-(1-hydroxyethyl)-2-carbonyl-penem-3carbons[ure, verfahren zur herstellung und sie enthaltende pharmazeutische zusammensetzungen.

Info

Publication number
ATE8400T1
ATE8400T1 AT81110740T AT81110740T ATE8400T1 AT E8400 T1 ATE8400 T1 AT E8400T1 AT 81110740 T AT81110740 T AT 81110740T AT 81110740 T AT81110740 T AT 81110740T AT E8400 T1 ATE8400 T1 AT E8400T1
Authority
AT
Austria
Prior art keywords
penem
carba
hydroxyethyl
carbonyl
3carbons
Prior art date
Application number
AT81110740T
Other languages
English (en)
Inventor
Lovji D. Cama
Ravindra Guthikonda
Burton G. Christensen
Original Assignee
Merck & Co. Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co. Inc. filed Critical Merck & Co. Inc.
Application granted granted Critical
Publication of ATE8400T1 publication Critical patent/ATE8400T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/14—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/10—Compounds having one or more C—Si linkages containing nitrogen having a Si-N linkage
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/568—Four-membered rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT81110740T 1980-12-24 1981-12-23 1-carba-6-(1-hydroxyethyl)-2-carbonyl-penem-3carbons[ure, verfahren zur herstellung und sie enthaltende pharmazeutische zusammensetzungen. ATE8400T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/219,629 US4321197A (en) 1980-12-24 1980-12-24 1-Carba-6-(1-hydroxyethyl)-2-carbonyl-penem-3-carboxylic acid and preparation thereof
EP81110740A EP0054971B1 (de) 1980-12-24 1981-12-23 1-Carba-6-(1-hydroxyethyl)-2-carbonyl-penem-3-Carbonsäure, Verfahren zur Herstellung und sie enthaltende pharmazeutische Zusammensetzungen

Publications (1)

Publication Number Publication Date
ATE8400T1 true ATE8400T1 (de) 1984-07-15

Family

ID=22820065

Family Applications (1)

Application Number Title Priority Date Filing Date
AT81110740T ATE8400T1 (de) 1980-12-24 1981-12-23 1-carba-6-(1-hydroxyethyl)-2-carbonyl-penem-3carbons[ure, verfahren zur herstellung und sie enthaltende pharmazeutische zusammensetzungen.

Country Status (5)

Country Link
US (1) US4321197A (de)
EP (1) EP0054971B1 (de)
JP (1) JPS57134484A (de)
AT (1) ATE8400T1 (de)
DE (1) DE3164780D1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59106489A (ja) * 1982-12-10 1984-06-20 Sanraku Inc 新規β−ラクタム誘導体及びその製造方法
US5371215A (en) * 1991-03-20 1994-12-06 American Cyanamid Company 4-substituted azetidinones as precursors to 2-substituted-3-carboxy carbapenem antibiotics and a method of producing them
US5455239A (en) * 1993-08-05 1995-10-03 Merck & Co. Inc. 3-aryl of heteroaryl-7-heteroaralkylamido cephalosporin compounds, compositions and methods of use
US5498777A (en) * 1994-07-20 1996-03-12 Merck & Co., Inc. 3-thioheteroaryl cephalosporin compounds, compositions and methods of use
US5565445A (en) * 1995-02-22 1996-10-15 Merck & Co., Inc. 3-thioheteroaryl 1-carba-1-dethiacephalosporin compounds, compositions and methods of use

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55147284A (en) * 1979-04-17 1980-11-17 Sanraku Inc Novel beta-lactam derivative and its preparation

Also Published As

Publication number Publication date
EP0054971A1 (de) 1982-06-30
DE3164780D1 (en) 1984-08-16
JPS57134484A (en) 1982-08-19
US4321197A (en) 1982-03-23
EP0054971B1 (de) 1984-07-11

Similar Documents

Publication Publication Date Title
ATE62485T1 (de) Indolizin-derivate, verfahren zur herstellung und diese enthaltende zusammensetzungen.
DE58902737D1 (de) Verfahren zur herstellung pharmazeutischer mischungen.
DK173883D0 (da) Substituerede 8-phenylxanthiner
ATE25525T1 (de) N-glycosylierte carbonsaeureamid-derivate, verfahren zu ihrer herstellung sowie ihre verwendung zur beeinflussung der koerpereigenen abwehr.
ZA811252B (en) New 3,4,5-trihydroxypiperdine compounds, their production, their medicinal use, and their use in animal nutrition
ATE98643T1 (de) Aralkylaminalkoxyphenyl-derivate, verfahren zur herstellung und sie enthaltende zusammensetzungen.
ATE9350T1 (de) Tricyclische cytosinderivate zur verwendung in arzneimitteln und verfahren zu ihrer herstellung.
ATE77239T1 (de) Zubereitung zur stimulation der chondrozyten und des osteoblastes (ossein-hydroxyapatitverbindung), verfahren zur herstellung und pharmazeutische produkten, die sie enthalten.
AU6319480A (en) 2-hydroxyalkyl-3,4,5-trihydroxypiperidines
ATE8400T1 (de) 1-carba-6-(1-hydroxyethyl)-2-carbonyl-penem-3carbons[ure, verfahren zur herstellung und sie enthaltende pharmazeutische zusammensetzungen.
ATE100095T1 (de) 2,2-dimethylchromenderivate, verfahren zur herstellung und diese enthaltende pharmazeutische zusammenstellungen.
ATE7782T1 (de) Derivate der phenylalkansaeure, verfahren zu deren herstellung und sie enthaltende pharmazeutische zusammensetzungen.
PT83309A (de) Neue pyrrolo-benzimidazole pyrrolo-benzoxazole und pyrrolo-benzthiazole verfahren zu ihrer herstellung und diese verbindungen enthaltende arneimittel
SE8803931D0 (sv) New alkoxy derivatives of ginkgolides, their preparation and therapeutic compositions containing the same
DE69103624D1 (de) Ipriflavone enthaltende pharmazeutische zubereitungen, verfahren zur herstellung und therapeutische verwendung.
DE3853926D1 (de) 2-Oxa-isocephem-Verbindungen, diese enthaltende Zusammensetzungen und Verfahren zur Herstellung dieser Verbindungen.
AU8329782A (en) Cyclic sulphenamide derivatives
ATE11911T1 (de) N-(1-allyl-2-pyrrolidinyl-methyl)-2-methoxy-4amino-5-methylsulfamoyl-benzamide, verfahren zur herstellung und verwendung als heilmittel.
ATE135T1 (de) 2-substituierte-3-heterocycloindole, verfahren zur herstellung und sie enthaltende pharmazeutische zusammensetzungen.
AU550741B2 (en) Oral composition for treatment of hematosis containing almitrin
PT76582B (de) 1,2,4-triazol-1-yl-propionitrile verfahren zur herstellung dieser verbindungen sowie diese enthaltende biozide mittel
ZA824730B (en) New antibiotic compounds, their production and their medicinal
DE3674250D1 (de) Phenylpyrazinderivate, verfahren zu deren herstellung, pharmazeutische zusammensetzung und verwendung.
ATE20360T1 (de) Polysaccharidsubstanz, verfahren zu deren herstellung, dieselbe enthaltende pharmazeutische zusammensetzungen sowie deren verwendung als medikamente.
ATE5315T1 (de) Substituierte caprylolactam-derivate als antihypertonika, verfahren zur herstellung und diese verbindungen enthaltende pharmazeutische zusammensetzung.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee